Literature DB >> 35060430

The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients.

Sonja Stieb1,2, Grete M Engeseth3,4, Abdallah S R Mohamed1, Renjie He1, Ismael Perez-Martinez1, Stockton Rock1, Tanaya S Deshpande1, Adam S Garden1, David I Rosenthal1, Steven J Frank1, G Brandon Gunn1, C David Fuller1.   

Abstract

BACKGROUND: To analyze the influence of radiation dose on late radiation-associated taste impairment in oropharyngeal cancer (OPC) patients treated with intensity-modulated radiotherapy (IMRT) using the taste bud bearing tongue mucosa as organ at risk.
MATERIAL AND METHODS: This study is part of an ongoing, prospective observational study. Cancer-free OPC survivors with at least 24 months from IMRT were included in this analysis. Scores for taste impairment and dry mouth were extracted from the MD Anderson Symptom Inventory Head and Neck module (MDASI-HN) with scores of ≥5 considered as moderate-to-severe symptoms. The mean dose, minimum and maximum dose to the taste bud bearing tongue mucosa, the ipsi- and contralateral parotid and submandibular glands were extracted and analyzed for correlation with moderate-to-severe taste impairment.
RESULTS: One hundred sixteen T1-4 OPC patients were included (81% males, median age: 55). The primary tumor was in the tonsil in 92 cases (79%) and in the base of tongue in 21 cases (18%). Patients were treated with 64.2-72.0 Gy; 37 patients (32%) received concurrent chemotherapy and 22 (19%) concurrent targeted therapy. After a median of 58 months from RT (IQR: 43-68) 38 patients (33%) suffered from moderate-to-severe long-term radiation-associated taste impairment. No dose volume parameter of the taste bud bearing tongue mucosa and the salivary glands was significantly associated with moderate-to-severe taste impairment for the whole patient cohort. For patients without concurrent chemotherapy, the minimum and mean dose to the ipsilateral parotid gland, and the maximum dose to the submandibular gland was significantly associated with late taste impairment (all p < 0.05). A significant correlation was found between taste impairment and dry mouth (p < 0.001).
CONCLUSION: The dose to the ipsilateral parotid gland seems to play an important role in the development of late taste impairment. The influence of dose to the taste bud bearing tongue mucosa remains unclear and needs further investigation.

Entities:  

Keywords:  Head and neck neoplasms; oropharyngeal cancer; radiotherapy; taste

Mesh:

Year:  2022        PMID: 35060430      PMCID: PMC8981169          DOI: 10.1080/0284186X.2021.2022204

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  16 in total

1.  Human papillomavirus and survival of patients with oropharyngeal cancer.

Authors:  K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison
Journal:  N Engl J Med       Date:  2010-06-07       Impact factor: 91.245

2.  Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes.

Authors:  Terence T Sio; Huei-Kai Lin; Qiuling Shi; G Brandon Gunn; Charles S Cleeland; J Jack Lee; Mike Hernandez; Pierre Blanchard; Nikhil G Thaker; Jack Phan; David I Rosenthal; Adam S Garden; William H Morrison; C David Fuller; Tito R Mendoza; Radhe Mohan; Xin Shelley Wang; Steven J Frank
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-02-18       Impact factor: 7.038

3.  Gustatory tissue injury in man: radiation dose response relationships and mechanisms of taste loss.

Authors:  K L Mossman
Journal:  Br J Cancer Suppl       Date:  1986

4.  Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.

Authors:  Eli Sapir; Yebin Tao; Felix Feng; Stuart Samuels; Issam El Naqa; Carol A Murdoch-Kinch; Mary Feng; Matthew Schipper; Avraham Eisbruch
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-05-17       Impact factor: 7.038

5.  Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial.

Authors:  Maura L Gillison; Andy M Trotti; Jonathan Harris; Avraham Eisbruch; Paul M Harari; David J Adelstein; Richard C K Jordan; Weiqiang Zhao; Erich M Sturgis; Barbara Burtness; John A Ridge; Jolie Ringash; James Galvin; Min Yao; Shlomo A Koyfman; Dukagjin M Blakaj; Mohammed A Razaq; A Dimitrios Colevas; Jonathan J Beitler; Christopher U Jones; Neal E Dunlap; Samantha A Seaward; Sharon Spencer; Thomas J Galloway; Jack Phan; James J Dignam; Quynh Thu Le
Journal:  Lancet       Date:  2018-11-15       Impact factor: 79.321

6.  Long-Term Taste Impairment after Intensity-Modulated Radiotherapy to Treat Head-and-Neck Cancer: Correlations with Glossectomy and the Mean Radiation Dose to the Oral Cavity.

Authors:  Wen-Cheng Chen; Ming-Shao Tsai; Yao-Te Tsai; Chia-Hsuan Lai; Chuan-Pin Lee; Miao-Fen Chen
Journal:  Chem Senses       Date:  2019-05-29       Impact factor: 3.160

7.  Development and validation of a contouring guideline for the taste bud bearing tongue mucosa.

Authors:  Sonja Stieb; Abdallah S R Mohamed; Renjie He; Lin L Zhu; Brigid A McDonald; Kareem Wahid; Lisanne V van Dijk; Juan Ventura; Sara Ahmed; Lance McCoy; Tanaya S Deshpande; Stephen Grant; Jay P Reddy; Jack Phan; Adam S Garden; David I Rosenthal; Steven J Frank; G Brandon Gunn; C David Fuller
Journal:  Radiother Oncol       Date:  2020-11-18       Impact factor: 6.901

Review 8.  Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review.

Authors:  Tanaya S Deshpande; Pierre Blanchard; Li Wang; Robert L Foote; Xiaodong Zhang; Steven J Frank
Journal:  Curr Treat Options Oncol       Date:  2018-11-09

9.  Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients ≥65 years old.

Authors:  Salman A Eraj; Mona K Jomaa; Crosby D Rock; Abdallah S R Mohamed; Blaine D Smith; Joshua B Smith; Theodora Browne; Luke C Cooksey; Bowman Williams; Brandi Temple; Kathryn E Preston; Jeremy M Aymard; Neil D Gross; Randal S Weber; Amy C Hessel; Renata Ferrarotto; Jack Phan; Erich M Sturgis; Ehab Y Hanna; Steven J Frank; William H Morrison; Ryan P Goepfert; Stephen Y Lai; David I Rosenthal; Tito R Mendoza; Charles S Cleeland; Kate A Hutcheson; Clifton D Fuller; Adam S Garden; G Brandon Gunn
Journal:  Radiat Oncol       Date:  2017-09-09       Impact factor: 3.481

10.  Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?

Authors:  Sonja Stieb; Abdallah S R Mohamed; Tanaya S Deshpande; Jared Harp; Benjamin Greiner; Adam S Garden; Ryan P Goepfert; Richard Cardoso; Renata Ferrarotto; Jack Phan; Jay P Reddy; William H Morrison; David I Rosenthal; Steven J Frank; C David Fuller; G Brandon Gunn
Journal:  Clin Transl Radiat Oncol       Date:  2020-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.